GS Investments’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,210
Closed -$134K 156
2022
Q1
$134K Hold
2,210
0.08% 86
2021
Q4
$203K Hold
2,210
0.1% 88
2021
Q3
$280K Sell
2,210
-15
-0.7% -$2.18K 0.15% 84
2021
Q2
$370K Hold
2,225
0.5% 34
2021
Q1
$404K Hold
2,225
0.88% 29
2020
Q4
$445K Hold
2,225
0.43% 59
2020
Q3
$488K Buy
+2,225
New +$471K 1.32% 20

Other funds holding TDOC

GS Investments's TDOC Position: Q2 2022 in Review

GS Investments sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 2,210 shares — an estimated $134K sold.

GS Investments first reported a position in TDOC in Q3 2020 and held it in 7 quarters. The position peaked at $488K in Q3 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • GS Investments reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • GS Investments sold 2,210 Teladoc Health shares in Q2 2022, an estimated $134K.
  • GS Investments first reported a position in Teladoc Health in Q3 2020 and held it in 7 quarters.
  • GS Investments's Teladoc Health position peaked at $488K in Q3 2020.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on GS Investments's 13F filing for Q2 2022, filed 3 Aug 2022.